Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00735865 · ClinicalTrials.gov registry record · NA
Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion
A NA study, sponsored by Lahey Clinic.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT00735865: Completed NA study, sponsored by Lahey Clinic.
NCT00735865 is a NA study that has completed, run by Lahey Clinic. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00735865, a NA study, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
To determine if the types and amount of bacteria or other germs change over time after the routine procedure of blockage of tear drainage duct in the treatment of dry eye condition or other condition benefiting from a tear drainage blockage
Interventions
- PROCEDURE Punctal plugs, punctal cautery
- PROCEDURE Punctal Plug, Punctal thermocauterization
- PROCEDURE Silicone plug or thermodynamic hydrophobic acrylic plug
- OTHER Previous subjects with Punctal occlusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2003-07 |
| Est. Completion | 2009-05 |
| Phase | NA |
What the finished NCT00735865 record still lists
NCT00735865 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Punctal plugs, punctal cautery is the first listed.
NCT00735865 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00735865 about?
NCT00735865 is a clinical study titled "Lid Margin And Conjunctival Microbial Flora Following Punctum Occlusion". To determine if the types and amount of bacteria or other germs change over time after the routine procedure of blockage of tear drainage duct in the treatment of dry eye condition or other condition benefiting from a tear drainage blockage
What is the current status of trial NCT00735865?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2003-07. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00735865?
The interventions under investigation include: Punctal plugs, punctal cautery (PROCEDURE), Punctal Plug, Punctal thermocauterization (PROCEDURE), Silicone plug or thermodynamic hydrophobic acrylic plug (PROCEDURE), Previous subjects with Punctal occlusion (OTHER).
Who is sponsoring clinical trial NCT00735865?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00735865's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia